Evotec SE (NAS:EVO)
$ 4.54 -0.34 (-6.97%) Market Cap: 1.61 Bil Enterprise Value: 1.77 Bil PE Ratio: 0 PB Ratio: 1.56 GF Score: 73/100

Half Year 2022 Evotec SE Earnings Call Transcript

Aug 11, 2022 / 12:00PM GMT
Release Date Price: $13.14 (+0.08%)
Operator

Good day, ladies and gentlemen, and welcome to the Evotec SE Half Year Report 2022 Conference Call. For information, today's conference is being recorded. And at this time, I'd like to turn the call over to your host today, Dr. Werner Lanthaler. Please go ahead, sir.

Werner Lanthaler
Evotec SE - Chairman of Management Board & CEO

Thank you very much, and good morning and a great day to everyone. Accelerating precision medicine, that's the theme of today's analyst presentation for our first half of 2022. Welcome to this. We have uploaded a presentation and will guide you through this presentation throughout the next couple of minutes.

If you go to Page #2, you can see that I'm here together with my team. I'm here with our CFO, Enno Spillner; our CSO, Cord Dohrmann; our COO, Craig Johnstone, and we are very happy to give you a brief update about our recent quarters and also an outlook for the remainder of '22 and into the longer aspirations of Evotec.

Our recently joined new colleague, Matthias Evers, is also on the call, and we are very

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot